• Pfizer average return on tangible equity for 2024 was -5.29, a 102.63% increase from 2023.
• Pfizer average return on tangible equity for 2023 was 200.79, a 108.91% decline from 2022.
• Pfizer average return on tangible equity for 2022 was -2253.24, a 711.54% decline from 2021.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.